zedie posted: " French biotech PulseSight Therapeutics launches today to develop minimally invasive, non-viral gene therapies for sight conditions such as age-related macular degeneration (AMD). The Paris-based startup has two late-stage preclinical gene " Read on blog or Reader SOMEONE SOMEWHERE Read on blog or Reader PulseSight Therapeutics Will Develop Next Generation Eye Gene Therapies zedie February 29 French biotech PulseSight Therapeutics launches today to develop minimally invasive, non-viral gene therapies for sight conditions such as age-related macular degeneration (AMD). The Paris-based startup has two late-stage preclinical gene therapy candidates. Its lead program for wet AMD, PST-809, and another for dry AMD or geographic atrophy, PST-611. The company has seed funding from Swiss […] Read more of this post Comment Like You can also reply to this email to leave a comment.

SOMEONE SOMEWHERE © 2024. Manage your email settings or unsubscribe. Get the Jetpack app Subscribe, bookmark, and get real-time notifications - all from one app! Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110